AP
Andy Pasternak
EVP, Chief Strategy Officer

Andy Pasternak insider trades: Horizon Therapeutics Public (HZNP) stock sales

EVP, Chief Strategy Officer, Horizon Therapeutics Public Last trade Jan 17, 2023 24 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2021
3
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Andy reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 17, 2023HZNP↓ Sell$3.1M
Dec 13, 2022HZNP↓ Sell$3.4M
Jul 29, 2022HZNP↓ Sell$400K
Jun 10, 2022HZNP↓ Sell$65K
Feb 18, 2022HZNP↓ Sell$124K
Jan 6, 2022HZNP↓ Sell$795K
Dec 7, 2021HZNP↓ Sell$153K
Nov 4, 2021HZNP↓ Sell$3.4M
Sep 9, 2021HZNP↓ Sell$2.5M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Andy Pasternak's insider trades

Andy Pasternak is EVP, Chief Strategy Officer at Horizon Therapeutics Public (HZNP). Since Sep 9, 2021, Andy has reported no open-market purchases and 9 sales worth $13.9M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (11 filings), option exercises (9 filings), shares withheld for taxes (8 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HZNP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.